Pangenomic Health Inc.
Simbol: NARA.CN
CNQ
0.08
CADTržna cena danes
-0.5178
Razmerje P/E
0.0003
Razmerje PEG
0.77M
Kapaciteta MRK
- 0.00%
Donos DIV
Pangenomic Health Inc. (NARA-CN) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.1 | 1.3 | 0 | ||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.net-receivables | 0 | 0.2 | 0 | 0.1 | ||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0.3 | 0 | ||||
balance-sheet.row.total-current-assets | 0 | 0.5 | 1.7 | 0.1 | ||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.intangible-assets | 0 | 0 | 0.8 | 0 | ||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0.8 | 0 | ||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 0.9 | 0 | ||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-assets | 0 | 0.5 | 2.6 | 0.1 | ||||
balance-sheet.row.account-payables | 0 | 0.4 | 0.2 | 0 | ||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 0 | 0 | ||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||
balance-sheet.row.other-current-liab | 0 | 0.2 | 0.2 | 0.1 | ||||
balance-sheet.row.total-non-current-liabilities | 0 | 0.5 | 0 | 0 | ||||
balance-sheet.row.other-liabilities | 0 | -0.5 | 0 | 0 | ||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-liab | 0 | 0.7 | 0.3 | 0.1 | ||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.5 | 0 | ||||
balance-sheet.row.common-stock | 0 | 11.2 | 4.6 | 0.2 | ||||
balance-sheet.row.retained-earnings | 0 | -15 | -3 | -0.3 | ||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 3.5 | 0.1 | 0.1 | ||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-stockholders-equity | 0 | -0.2 | 2.2 | 0 | ||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0.5 | 2.6 | 0.1 | ||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-equity | 0 | -0.2 | 2.2 | 0 | ||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||
Total Investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-debt | 0 | 0.1 | 0 | 0 | ||||
balance-sheet.row.net-debt | 0 | 0 | -1.3 | 0 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -12 | -2.6 | -0.1 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||
cash-flows.row.deferred-income-tax | 0 | 0 | 1.8 | 0 | ||||
cash-flows.row.stock-based-compensation | 0 | 0.6 | 0.1 | 0 | ||||
cash-flows.row.change-in-working-capital | 0 | 0.2 | -0.3 | 0.1 | ||||
cash-flows.row.account-receivables | 0 | -0.1 | 0 | 0 | ||||
cash-flows.row.inventory | 0 | 0.1 | 0 | 0 | ||||
cash-flows.row.account-payables | 0 | 0.2 | 0.1 | 0 | ||||
cash-flows.row.other-working-capital | 0 | 0 | -0.3 | 0.1 | ||||
cash-flows.row.other-non-cash-items | 0 | 8.4 | 0 | 0 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | ||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.6 | -0.1 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.1 | -0.6 | -0.1 | ||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 2.5 | 0.1 | ||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-financing-activites | 0 | 0.4 | 0.5 | 0 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1.6 | 3 | 0.2 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||
cash-flows.row.net-change-in-cash | 0 | -1.3 | 1.3 | 0 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 0.1 | 1.3 | 0 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1.3 | 0 | 0 | ||||
cash-flows.row.operating-cash-flow | 0 | -2.8 | -1.1 | 0 | ||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | ||||
cash-flows.row.free-cash-flow | 0 | -2.8 | -1.1 | 0 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.research-development | 0 | - | - | - | ||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.operating-expenses | 0 | 3.6 | 0.9 | 0.1 | ||||
income-statement-row.row.cost-and-expenses | 0 | 3.6 | 0.9 | 0.1 | ||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.total-other-income-expensenet | 0 | -8.4 | -1.8 | 0 | ||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.total-operating-expenses | 0 | -8.4 | -1.8 | 0 | ||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||
income-statement-row.row.operating-income | 0 | -3.6 | -0.9 | -0.1 | ||||
income-statement-row.row.income-before-tax | 0 | -12 | -2.6 | -0.1 | ||||
income-statement-row.row.income-tax-expense | 0 | 8.4 | 0 | 0 | ||||
income-statement-row.row.net-income | 0 | -20.3 | -2.7 | -0.1 |
Pogosto zastavljeno vprašanje
Kaj je Pangenomic Health Inc. (NARA.CN) skupna sredstva?
Pangenomic Health Inc. (NARA.CN) skupna sredstva so 504142.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.000.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.016.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.000.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.000.
Kaj je Pangenomic Health Inc. (NARA.CN) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -20347972.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 101771.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 3641827.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.